Internal Medicine, Nephrology · Boston, MA
NPI
1225076771
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
Brigham and Womens Hospital Renal Division, Harvard Institute of Medicine
Boston, MA, 02115
Phone (617) 525-5876
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
619 services
Medicare patients, 2024
208
Average age 74
Drug cost, 2024
$631K
501 prescriptions
Company payments, 2025
$201
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David B Mount was code 99233 (hospital e&m - subsequent), 152 times for 65 patients. In total David B Mount billed 619 services in 12 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 152 | 65 | $95.48 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 129 | 67 | $64.54 | $8,326 |
| 99215 Office E&M - Established | Facility | 108 | 59 | $112.48 | $12K |
| 99214 Office E&M - Established | Facility | 98 | 69 | $73.35 | $7,188 |
| 90935 Hemodialysis | Facility | 49 | 26 | $58.28 | $2,856 |
| 99222 Hospital E&M - Initial | Facility | 37 | 36 | $107.69 | $3,985 |
| 99223 Hospital E&M - Initial | Facility | 26 | 24 | $142.79 | $3,712 |
By year: 2022 $61K for 718 services; 2023 $63K for 656 services; 2024 $54K for 619 services.
Medicare prescription drug claims, 2024
In 2024, the drug David B Mount prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 55 prescriptions and refills. In total David B Mount wrote 501 Medicare prescriptions that cost $631K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 55 | 117 | 17 | $224 |
| Jardiance Empagliflozin | 50 | 120 | 14 | $69K |
| Tavneos Avacopan | 32 | 34 | Under 11 | $513K |
| Carvedilol Generic | 26 | 51 | Under 11 | $232 |
| Amlodipine Besylate Generic | 22 | 66 | Under 11 | $385 |
| Losartan Potassium Generic | 21 | 63 | Under 11 | $316 |
| Calcitriol Generic | 21 | 49 | Under 11 | $361 |
| Torsemide Generic | 20 | 56 | 11 | $459 |
| Metoprolol Succinate Generic | 17 | 29 | Under 11 | $169 |
| Furosemide Generic | 17 | 51 | Under 11 | $112 |
| Nifedipine Er Nifedipine | 17 | 49 | Under 11 | $512 |
| Allopurinol Generic | 17 | 51 | Under 11 | $116 |
| Lisinopril Generic | 16 | 46 | Under 11 | $77.11 |
| Atovaquone Generic | 14 | 19 | Under 11 | $6,923 |
| Tamsulosin Hcl Generic | 13 | 39 | Under 11 | $346 |
Brand drugs: 113 claims; generic drugs: 388 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David B Mount $201 ($201 in general payments such as food, travel and fees) from 4 companies. The largest payer was NxStage Medical, Inc. with $101.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.